Evans John M.
SEC CIK 1786304 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | CEO, Dir | 1.07M | — | $34.97M | 44 | 2021-07-07 | 2026-06-29 |
Most active insiders at BEAM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FMR LLC | 10%, See Remark 1 | — | $10.05M |
| 2 | Evans John M. | CEO, Dir | — | $6.28M |
| 3 | Ciaramella Giuseppe | Pres | — | $1.41M |
| 4 | Bellon Christine | CLO | — | $881.0K |
| 5 | Simon Amy | Chief Medical Off | — | $606.7K |
| 6 | Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| 7 | Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-01 16:05 | 2026-06-29+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $0.8956 | +50.0K | 1.07M | +5% | +$44.8K |
| DMT | 2026-07-01 16:05 | 2026-06-29+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $34.90 | -50.0K | 1.05M | -5% | -$1.75M |
| T | 2026-04-06 17:48 | 2026-04-01 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $24.58 | -30.1K | 1.05M | -3% | -$739.3K |
| DMT | 2026-04-01 18:32 | 2026-03-30+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +50.0K | 1.01M | +5% | +$33.5K |
| DMT | 2026-04-01 18:32 | 2026-03-30+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $22.57 | -50.0K | 986.7K | -5% | -$1.13M |
| DT | 2026-04-01 18:32 | 2026-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | A - Grant | $0.00 | +90.0K | 1.08M | +9% | $0 |
| DMT | 2026-02-02 | 2026-01-29+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $28.87 | -50.0K | 986.7K | -5% | -$1.44M |
| DMT | 2026-02-02 | 2026-01-29+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +50.0K | 1.01M | +5% | +$33.5K |
| DMT | 2025-10-03 | 2025-10-01+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $24.57 | -50.0K | 986.7K | -5% | -$1.23M |
| DMT | 2025-10-03 | 2025-10-01+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +50.0K | 1.01M | +5% | +$33.5K |
| T | 2025-04-03 | 2025-04-01 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $18.35 | -30.7K | 986.2K | -3% | -$562.7K |
| 2025-04-02 | 2025-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | A - Grant | $0.00 | +77.5K | 1.02M | +8% | $0 | |
| DAT | 2025-04-02 | 2025-01-30 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $0.67 | +30.0K | 968.7K | +3% | +$20.1K |
| DMT | 2025-02-03 | 2025-01-30 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $26.75 | -30.0K | 908.9K | -3% | -$802.6K |
| T | 2024-10-02 | 2024-09-30 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $24.60 | -60.0K | 938.7K | -6% | -$1.48M |
| T | 2024-06-28 | 2024-06-27 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $24.50 | -60.0K | 998.3K | -6% | -$1.47M |
| DT | 2024-04-03 | 2024-04-01 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $32.13 | -18.1K | 1.06M | -2% | -$581.6K |
| T | 2024-04-01 | 2024-03-28 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $33.86 | -60.0K | 998.3K | -6% | -$2.03M |
| T | 2024-04-01 | 2024-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | A - Grant | $0.00 | +77.5K | 1.08M | +8% | $0 |
| DT | 2024-02-02 | 2024-01-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $25.33 | -60.0K | 1.06M | -5% | -$1.52M |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $29.63 | -11.7K | 1.12M | -1% | -$345.3K |
| D | 2023-03-31 | 2023-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | A - Grant | $0.00 | +56.2K | 1.12M | +5% | $0 |
| D | 2023-03-31 | 2023-03-06 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | L - Small Acq | $0.00 | +225 | 1.06M | +0.0% | $0 |
| D | 2023-03-31 | 2023-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $7.22 | +13.8K | 1.13M | +1% | +$100.0K |
| M | 2022-11-02 | 2022-10-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $46.30 | -30.0K | 1.07M | -3% | -$1.39M |
| MI | 2022-11-02 | 2022-10-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $46.36 | -20.0K | 118.0K | -14% | -$927.2K |
| MI | 2022-07-29 | 2022-07-28 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $65.78 | -20.0K | 125.4K | -14% | -$1.32M |
| M | 2022-07-29 | 2022-07-28 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $65.75 | -30.0K | 1.11M | -3% | -$1.97M |
| DM | 2022-05-02 | 2022-04-28 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $2.31 | +59.5K | 1.10M | +6% | +$137.0K |
| DM | 2022-05-02 | 2022-04-28 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $37.98 | -30.0K | 1.12M | -3% | -$1.14M |
| DMI | 2022-05-02 | 2022-04-28 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $37.98 | -20.0K | 143.0K | -12% | -$759.6K |
| 2022-04-04 | 2022-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale | $59.11 | -6,261 | 1.09M | -0.6% | -$370.1K | |
| 2022-04-04 | 2022-03-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | A - Grant | $0.00 | +56.2K | 1.10M | +5% | $0 | |
| DMAI | 2022-02-02 | 2022-01-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $66.85 | -20.0K | 181.1K | -10% | -$1.34M |
| DA | 2022-02-02 | 2022-01-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +100.0K | 1.04M | +11% | +$103.0K |
| DMA | 2022-02-02 | 2022-01-31 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $66.83 | -30.0K | 968.0K | -3% | -$2.00M |
| DA | 2022-02-02 | 2021-11-16 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | G - Gift | $0.00 | -12.0K | 968.8K | -1% | $0 |
| DM | 2021-10-08 | 2021-10-06 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $83.80 | -27.7K | 1.04M | -3% | -$2.32M |
| DMI | 2021-10-08 | 2021-10-06 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $83.80 | -20.0K | 183.0K | -10% | -$1.68M |
| D | 2021-10-08 | 2021-10-06 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +27.7K | 1.06M | +3% | +$28.5K |
| DMI | 2021-08-20 | 2021-08-19 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $99.49 | -20.0K | 208.8K | -9% | -$1.99M |
| D | 2021-08-20 | 2021-08-19 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +12.0K | 1.03M | +1% | +$12.4K |
| DM | 2021-07-08 | 2021-07-07 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | S - Sale+OE | $107.87 | -25.0K | 1.02M | -2% | -$2.70M |
| D | 2021-07-08 | 2021-07-07 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +25.0K | 1.05M | +2% | +$25.8K |
Purchase Sale Sale after option exercise All abbreviations